DRW Securities, LLC
Broker-DealerPosition in ESPR — Esperion Therapeutics, Inc.
CIK 1481986
CHICAGO, IL
Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
New position
Shares Held
33,285
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DRW Securities, LLC holds $1,370,922 across 7 Drug Manufacturers - Specialty & Generic names. ESPR ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
22,425 | $359,472 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
31,234 | $312,340 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
2,831 | $234,350 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,809 | $230,688 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
373 | $202,102 | |
| 6 | CRON |
Cronos Group Inc.
|
11,500 | $31,970 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
This page
|
33,285 | $0 |
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 33,285 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||